January 2017 FDA Recall Drug by Hospira Inc., A Pfizer Company
D-0638-2017 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Hospira Inc., A Pfizer Company on January 24, 2017 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0638-2017

Reason for Recall
Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.
Initiated
01-24-2017
Reported
04-12-2017
Quantity
30,880 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Hospira Inc., A Pfizer Company
Vancomycin Hydrochloride for Injection, USP, 10 grams, Pharmacy Bulk Package - Not For Direct Infusion, For Intravenous Use, packaged in 100 mL glass vial, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6510-01

Batch or Lot Expiration Information

Lot# 591053A, Exp 11/1/2017